Xenon Pharmaceuticals’ stock falls as depression treatment has mixed results in clinical trial
November 27, 2023 at 08:30 AM EST
Xenon Pharmaceuticals shares fell early Monday after the company released new clinical-trial data on an experimental depression treatment.
